North America Medical Cyclotron Market
The medical cyclotron market in North America is expected to grow from US$ 91.67 million in 2022 to US$ 152.68 million by 2028; it is estimated to register a CAGR of 8.9% from 2022 to 2028.
Cyclotron therapy is commonly used for the treatment of various types of cancer. The prevalence of cancer is rising every year. Moreover, proton beam therapy is used to treat tumors that do not spread in the body; thus, they do not require surgery. Further, brain and spinal cord cancers are prevalent. The procedure is suitable for children as it prevents damaging healthy and growing tissues. Furthermore, it is used to treat different types of eye cancers such as orbital rhabdomyoma sarcoma and retinoblastoma. Radiotherapy is a scientifically sophisticated way to diagnose and treat cancer. According to the National Cancer Institute, the US government spent US$ 208.9 billion on cancer treatment in 2020. The increase in the development of artificial radionuclides, a surge in the number of therapies, and a rise in the prevalence of cancer are driving the growth of the medical cyclotrons market in North America.
North America Medical Cyclotron Market Revenue and Forecast to 2028 (US$ Million)
North America Medical Cyclotron Market Segmentation
The North America medical cyclotron market is segmented into type, capacity, end user, and country. Based on type, the market is bifurcated into ring cyclotron and azimuthally varying fields (AVF). The ring cyclotron segment held the larger share of the market in 2022. Based on capacity, the market is segmented into 10-12 MeV, 16-18 MeV, 19-24 MeV, and 24 MeV and above. In 2022, the 16-18 MeV segment held the largest share of the market. Based on end user, the market is categorized into hospitals, specialized clinics, pharmaceutical companies, and others. In 2022, the hospitals segment held the largest share of the market. Based on country, the North America medical cyclotron market is segmented into the US, Canada, and Mexico. Further, the US held the largest share of the market in 2022.
A few of the key players operating in the North America medical cyclotron market are Advanced Cyclotron Systems; ALCEN; Best ABT Molecular Imaging, Inc; Best Cyclotron Systems, Inc.; General Electric Company; IBA; Ionetix Corporation; isoSolution Inc.; Siemens AG; and Sumitomo Heavy Industries, Ltd.
The North America Medical Cyclotron Market is valued at US$ 91.67 Million in 2022, it is projected to reach US$ 152.68 Million by 2028.
As per our report North America Medical Cyclotron Market, the market size is valued at US$ 91.67 Million in 2022, projecting it to reach US$ 152.68 Million by 2028. This translates to a CAGR of approximately 8.9% during the forecast period.
The North America Medical Cyclotron Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Medical Cyclotron Market report:
The North America Medical Cyclotron Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Medical Cyclotron Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Medical Cyclotron Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Medical Cyclotron Market
